Answers are grounded in this paper and cite their sources.
Chylous ascites (CA) is uncommon in cirrhosis. It often presents as diuretic-resistant ascites and is associated with increased mortality. Diagnosis is done by the detection of triglyceride-rich ascitic fluid. There are no published guidelines on the management of CA. We describe the case of a middle-aged female who presented with CA secondary to cirrhosis, and the challenges associated with her treatment and her management with the use of intravenous octreotide.
No takes yet. Share an insight, caveat, or question.
Ghimire et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: